Website trial · enquiries welcome
Ask a questionDiscuss your project
WhatsApp ↗
NUTRAGUILD / OEM & ODM

Softgel supplement ODM & OEM: D3/K2 quotation guide

Compare vitamin D3 and K2 softgel quotations for a US brand: ingredient forms, serving units, fill, shell, packaging, sample checks and batch documents.

Dosage format illustration

NutraGuild · Updated

Procurement planning guidance. Confirm requirements for your product, formulation version and market.

What must match before you compare D3/K2 quotes?

Give each supplier the same dated brief: vitamin forms and amounts, softgels per serving, fill and shell specification, count per pack, order quantity, test scope and delivery terms. A lower bottle price is not directly comparable when any of these differ. NutraGuild coordinates ODM development or OEM discussions with its manufacturing partner and does not own a factory. A D3/K2 concept still requires formulation, manufacturing and US-market review for the actual version.

State each vitamin form and amount

  • Specify vitamin D3, its material specification and requested source. If a supplier proposes another vitamin D form or source, record it as a change for review.
  • Identify the requested vitamin K2 form, such as MK-4 or MK-7, and its material specification. NIH lists these as different forms used in supplements; the words vitamin K2 alone do not define the material being quoted.
  • Record each vitamin amount per softgel and per proposed serving, including the number of softgels per serving. Identify whether a quoted amount describes the vitamin itself or an ingredient preparation containing it.
  • Use consistent units when comparing vitamin D amounts: NIH gives 1 mcg vitamin D as equivalent to 40 IU. This is a unit conversion, not a recommended dose or an approved label declaration.
  • Mark unresolved amounts and ingredient choices as proposed. Serving amounts, intended users and label wording need review for the actual product.

Separate the active ingredients, fill and shell

Request the composition and target mass of the fill separately from the amounts of D3 and K2. Identify the proposed carrier, other ingredients, permitted substitutions and source restrictions. Specify shell material, color, size and shape independently. A fill-weight figure does not establish vitamin content, and a shell preference does not establish the sourcing of everything inside it. Availability and compatibility of the requested combination remain subject to the manufacturing team's assessment.

Compare the same finished pack

  • Match the number of softgels per bottle or blister and the number of saleable packs quoted.
  • Specify container, closure, seal, label revision and carton configuration; identify any proposed protective components for evaluation.
  • Request the planned storage and stability assessment for the actual formula and pack. Do not assume that an ingredient supplier's shelf life transfers to the finished softgel.
  • List packaging components, printed variants and packing work included in the price, with exclusions and component minimums stated separately.

Tie sample approval to a written specification

Identify samples by formula, fill, shell and packaging revision. Agree what each sample is intended to demonstrate and record differences from the proposed production version. Compare size, appearance and handling under the same written conditions, and request the team's plan for any compatibility or performance checks. Sensory or appearance acceptance does not establish vitamin content, shelf life or finished-batch conformity.

Define testing and batch-document scope

Request the proposed specifications, test methods, acceptance limits and responsible laboratory for the finished product. Clarify how both vitamins and the other agreed quality attributes will be assessed, and what batch documents will be supplied for release. 21 CFR 111.70 addresses component, finished-product, packaging and labeling specifications; it is not a universal test panel or a certification of this project. Tie the COA, lot identifier and release decision to the agreed specification. A raw-material COA alone does not establish the results for the finished softgel.

Turn the softgel MOQ into finished-pack questions

The partner baseline recorded September 15, 2026 is 150,000 individual softgels. At 60 softgels per bottle, that is 2,500 bottles before agreed allowances. This is planning arithmetic, not a guaranteed saleable quantity or a confirmed MOQ for every D3/K2 formula. Request the production and packaging minimums separately, including how formula strengths, shell changes and label variants affect the quotation. Confirm sampling and retained units, process allowances and the final pack count in writing.

Put every cost and responsibility in writing

  • Compare price per softgel and per finished pack on the same formula, quantity, currency and delivery basis.
  • Separate development work, sample revisions, testing, packaging, freight and other stated charges from the recurring product price.
  • Request price validity, payment terms, and separate sample and production timelines with their start conditions; this guide does not establish those terms.
  • Identify the contracting party, actual manufacturing site, specification approver and batch-release responsibility before a production commitment.
  • Send NutraGuild the controlled formula for OEM, or the concept and open decisions for ODM, together with this quotation basis. Feasibility, commercial terms and responsibilities are confirmed for your project.

Sources and further guidance

External guidance supports the review topics above; it does not certify NutraGuild, its partner or a product. Consult current requirements for your project.

Discuss this format
9 products
LET’S DEFINE YOUR NEXT PRODUCT

Bring your brief. Let’s build the next step.

Tell us your product, target market and estimated quantity. We will use your brief to scope formulation, samples, packaging and a project-specific quotation.

Discuss your project